エピソード

  • S16 E06 Embracing Canadian Biotech Innovation

    S16 E06 Embracing Canadian Biotech Innovation
    2026/08/26

    CEO and co-founder of Celystra Pharma’s Paul Levesque discusses Canadian biotech, rare disease policy, and AI as a healthcare accelerator.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    40 分
  • S16 E05 UCB Canada’s Rodrigo Reis on Fast Tracking Diagnosis and Patient Access

    S16 E05 UCB Canada’s Rodrigo Reis on Fast Tracking Diagnosis and Patient Access
    2026/08/19

    General Manager of UCB Canada’s Rodrigo Reis discusses patient-centric innovation, authentic sustainability, and strengthening digital capabilities.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    46 分
  • S16 E04 Bringing Innovative Therapies to Canada

    S16 E04 Bringing Innovative Therapies to Canada
    2026/06/24

    Associate Vice-President and GM of Incyte’s Chris White discusses Most Favoured Nation pricing impacts, drug access and reimbursement, and wildly authentic leadership.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    29 分
  • S16 E03 Learning to Do More With Less: Leandra Wells on How to Rethink Pharma Strategy

    S16 E03 Learning to Do More With Less: Leandra Wells on How to Rethink Pharma Strategy
    2026/06/17

    Founder of Brighthive Innovation Group’s Leandra Wells discusses tech enablement, transforming organization on lean budgets, and prioritizing healthcare in Canada.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    27 分
  • S16 E02 Healthcare Investing and Life Sciences Innovation in 2026: Bloom’s View

    S16 E02 Healthcare Investing and Life Sciences Innovation in 2026: Bloom’s View
    2026/06/03

    CEO of Bloom Burton’s Brian Bloom discusses the themes of the 2025 Bloom Burton conference, return entrepreneurs in the Canadian Life Sciences landscape, and accelerating drug discovery with AI.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    32 分
  • S16 E01 Overcoming Misconceptions about the Canadian Pharma Market

    S16 E01 Overcoming Misconceptions about the Canadian Pharma Market
    2026/05/27

    Canadian General Manager of argenx’s John Haslam discusses the big impact of rare disease, making key antibodies in the autoimmune space, and pricing strategy reform in Canada.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    32 分
  • S15 E08 The Inevitability of AI in Healthcare

    S15 E08 The Inevitability of AI in Healthcare
    2026/04/22

    CEO of Toboggan Labs’ Florencia Herra Vega discusses AI compliance and innovation, applying AI to the whole team instead of individually, and useful technology for quick solutions.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    42 分
  • S15 E07 The Importance of Commercial Product Pre-Launch

    S15 E07 The Importance of Commercial Product Pre-Launch
    2026/03/25

    Country Manager of Merz Therapeutics’ Mike Stone discusses commercial launches, the speed of mid-sized pharma, and rebranding DEI.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    続きを読む 一部表示
    32 分